before they do that they must still have to convince fda through characterisation that the product in gvhd 001 trial was enhanced versus previous less convincing rials.
then they can show the product in that trial matches commercial inventory. i think thats the easy part because it is exactly the same product quoted by silviu and is being manufactued consistently as confirmed by manufacturing inspection.
Ann: Mesoblast 2024 Half Year Financial Results Webcast, page-56
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |